• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Boston Biomedical

edit

Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.

Recent Milestones

edit

• 
  Boston Biomedical was acquired by Dainippon Sumitomo. (2/29/12)
  Posted 3/1/12 at 7:49pm via genengnews.com
• 
  Boston Biomedical — signed a license agreement with Dainippon Sumitomo Pharma Co. Ltd. of Osaka, Japan, for BBI's BBI608 candidate compound for all oncology indications (4/11/11)
  Posted 4/12/11 at 7:56am via masshightech.com

Videos

Screenshots

edit

Above: Boston Biomedical
Uploaded: 4/12/11

Sources

1. Dainippon Sumitomo Pharma to Snag Boston Biomedical for $200M (genengnews.com) [edit]
Boston Biomedical in $15 million-plus deal with Dainippon (masshightech.com) [edit]